CIK 0001285550 · Non-accelerated filer<br>Smaller reporting company
ClearPoint Neuro, Inc.
Sign in to watch- Ticker
- CLPT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582394628
- Phone
- 9499006833
- Business address
- 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CA, 92075
- Former names
- MRI INTERVENTIONS, INC., SURGIVISION INC, SURGI VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | FLETCHER R JOHN Director | Grant or award | +422 | $13.68 | $6K | 116,662 |
| 2025-12-31 | STIGALL L. JEREMY Chief Business Officer | Grant or award | +1 | $9.57 | $10 | 72,356 |
| 2025-12-31 | SABRA MAZIN Chief Operating Officer | Grant or award | +386 | $9.57 | $4K | 44,470 |
| 2025-12-31 | D'Alessandro Danilo Chief Financial Officer | Grant or award | +407 | $9.57 | $4K | 70,330 |
| 2025-12-31 | BURNETT JOSEPH CEO and President | Grant or award | +254 | $9.57 | $2K | 11,565 |
| 2025-11-21 | D'Alessandro Danilo Chief Financial Officer | Option exercise | +3,555 | $8.10 | $29K | 69,923 |
| 2025-11-21 | D'Alessandro Danilo Chief Financial Officer | Option exercise · Stock Options (right to buy) | −3,555 | 12,082 | ||
| 2025-10-10 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −17,583 | $26.51 | $466K | 225,939 |
| 2025-10-10 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −6,599 | $27.64 | $182K | 219,340 |
| 2025-10-10 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −1,981 | $28.64 | $57K | 217,359 |
| 2025-10-10 | BURNETT JOSEPH CEO and President | Sale 10b5-1 | −300 | $29.21 | $9K | 217,059 |
| 2025-10-10 | SABRA MAZIN Chief Operating Officer | Shares withheld for taxes | −7,480 | $26.11 | $195K | 44,084 |
| 2025-10-01 | FLETCHER R JOHN Director | Grant or award | +265 | $21.79 | $6K | 116,240 |
| 2025-10-01 | Girin Pascal E R Director | Grant or award | +315 | $21.79 | $7K | 96,949 |
| 2025-10-01 | Richards Timothy T. Director | Grant or award | +555 | $21.79 | $12K | 78,870 |
| 2025-07-01 | Richards Timothy T. Director | Grant or award | +934 | $11.94 | $11K | 78,315 |
| 2025-07-01 | Girin Pascal E R Director | Grant or award | +523 | $11.94 | $6K | 96,634 |
| 2025-07-01 | FLETCHER R JOHN Director | Grant or award | +484 | $11.94 | $6K | 115,975 |
| 2025-06-30 | D'Alessandro Danilo Chief Financial Officer | Grant or award | +376 | $10.15 | $4K | 66,368 |
| 2025-06-30 | STIGALL L. JEREMY Chief Business Officer | Grant or award | +1,608 | $10.15 | $16K | 72,355 |
Page 6 of 15 · 296 trades